Optimizing free fibular grafting in femoral head osteonecrosis: The Ioannina aiming device

Citation
Ae. Beris et Pn. Soucacos, Optimizing free fibular grafting in femoral head osteonecrosis: The Ioannina aiming device, CLIN ORTHOP, (386), 2001, pp. 64-70
Citations number
21
Categorie Soggetti
Ortopedics, Rehabilitation & Sport Medicine","da verificare
Journal title
CLINICAL ORTHOPAEDICS AND RELATED RESEARCH
ISSN journal
0009921X → ACNP
Issue
386
Year of publication
2001
Pages
64 - 70
Database
ISI
SICI code
0009-921X(200105):386<64:OFFGIF>2.0.ZU;2-8
Abstract
The extracapsular placement of a vascularized fibular graft in the subchond ral region of the femoral head now is a widely accepted method for treating patients with osteonecrosis of the femoral head, The effectiveness of the fibular graft seems to be dependent on precise placement in a biologically and anatomically relevant site within the femoral head, The current authors present the Ioannina technique for application of a new computer-aided des ign and computer-aided manufacturing process in the treatment of osteonecro sis of the femoral head using free vascularized fibular transplantation. Th e objective was to develop a computer-assisted design and manufacturing sys tem for an accurate and easier approach to the necrotic area in the femoral head. The Ioannina technique uses serial computed tomography scans of the proximal femur to identify the configuration of the proximal femur, and the size, location, and configuration of the lesion using a computer-aided des ign and computer-aided manufacturing process. Optimal graft placement is de termined and a guide wire canal is drilled into an patient-specific aiming device. In this process, identification of the optimal graft location is re lated to achieving that location surgically. The more arbitrary placement o f the graft during conventional fibular graft surgery leads to accurate gra ft placement in only 55% of the patients, whereas the use of the patient-sp ecific Ioannina aiming device resulted in optimal graft placement in 89% of the patients.